To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Valeant offers discounts on heart drugs

After heavy criticism by Congress and others, Valeant Pharmaceuticals is offering a discount program on its heart drugs Nitropress and Isuprel. Read more

Opioid patients lack access to treatment

There is a growing need for improved access to medication-assisted treatment among patients with opioid use disorder. Find out why

CONTINUING PHARMACY EDUCATION

Keep your patients moving: An overview of treatment options for constipation

This month's CE activity, "Keep your patient moving: An overview of treatment options for constipation," is open for pharmacists and pharmacy technicians.
The goal of this program is to assist pharmacists and pharmacy technicians in their understanding of the role of linaclotide, lubiprostone, methylnaltrexone, and naloxegol in the treatment of constipation after conventional nonpharmacologic interventions and conventional laxatives such as bulking agents, osmotic laxatives, and stimulant laxatives have failed.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Opdivo snags two new cancer approvals

Bristol-Myers Squibb's Opdivo, already approved to treat several different cancers, just received FDA approval for two additional cancer types. Read more

May 20, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Related Articles

Top 7 new facts about drug spending

CDC issues opioid prescribing guidelines

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us